Iron 3 acetylacetonate

Manufactured by Thermo Fisher Scientific

Sourced in United States, Belgium

Iron(III) acetylacetonate is a coordination complex that consists of one iron(III) ion coordinated to three acetylacetonate ligands. It is a crystalline solid that is used as a precursor in the synthesis of various iron-containing materials.

Automatically generated - may contain errors

Lab products found in correlation

Oleic acid, by Merck Group (4 mentions) 4 biphenylcarboxylic acid, by Thermo Fisher Scientific (3 mentions) Dibenzyl ether, by Thermo Fisher Scientific (2 mentions) Glycol chitosan, by Merck Group (1 mentions) 5β cholanic acid, by Merck Group (1 mentions) N hydroxysuccinimide nhs, by Merck Group (1 mentions) Polycaprolactone, by Merck Group (1 mentions) Dulbecco s modified eagle s medium dmem, by Thermo Fisher Scientific (1 mentions) Foetal bovine serum (fbs), by Thermo Fisher Scientific (1 mentions) Mesencult msc basal medium, by STEMCELL (1 mentions) Mesencult stimulatory supplement, by STEMCELL (1 mentions) Calcein acetoxymethyl ester calcein am, by Yeasen (1 mentions) Branched polyethylenimine pei, by Merck Group (1 mentions) Tetrahydrofuran, by Sinopharm (1 mentions) Chloroform, by Sinopharm (1 mentions) 4 6 diamidino 2 phenylindole (dapi), by Yeasen (1 mentions) Calcium chloride dihydrate, by Thermo Fisher Scientific (1 mentions) Nickel 2 acetylacetonate, by Thermo Fisher Scientific (1 mentions) D glucose, by Merck Group (1 mentions) Cytosine, by Merck Group (1 mentions)

Close spelling variants of this product

Iron (III) acetylacetonate ((Fe(acac)3) (5 citations) Iron acetylacetonate (3 citations)

8 protocols using iron 3 acetylacetonate

Synthesis of Iron Oxide Nanocubes

Check if the same lab product or an alternative is used in the 5 most similar protocols

The synthesis of the iron oxide
NCs has been extensively described by Kim et al.^{46 (link)} Briefly, Iron(III) acetylacetonate (0.71 g), Oleic acid
(1.27 g), benzyl ether (10.40 g), and 4-biphenylcarbocylic (0.41 g)
are mixed in a three neck flask, and then degassed by nitrogen gas
(1 h) before reaction. The mixture is heated up to 290 °C and
kept react for 30 min. The mixture is then cooled down and the produced
nanocubes can be precipitated by ethanol. A magnetic separator of
Dexter Magnetic Technologies Inc. (Elk Grove Village, IL) is employed
to remove supernatant. The purified nanocubes are resuspended in chloroform.
Iron(III) acetylacetonate, 4-biphenylcarboxylic acid, and benzyl ether
are from Thermo Fisher Scientific Inc. (Waltham, MA). Oleic acid is
obtained from Sigma-Aldrich Corp (St. Louis, MO).

Cervadoro A., Cho M., Key J., Cooper C., Stigliano C., Aryal S., Brazdeikis A., Leary J.F, & Decuzzi P. (2014). Synthesis of Multifunctional Magnetic NanoFlakes for Magnetic Resonance Imaging, Hyperthermia, and Targeting.. ACS Applied Materials & Interfaces, 6(15), 12939-12946.

+ Open protocol

+ Expand

Glycol Chitosan-Based Targeted Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols

Glycol chitosan (molecular weight =250 kDa, degree of deacetylation =82.7%), 5β-cholanic acid, 1-ethyl-3-(3-dimethylamniopropyl)-carbodiimide (EDC) hydrochloride, and N-hydroxysuccinimide (NHS) were ordered from Sigma-Aldrich Co. (St Louis, MO, USA) as reagent grade and used without further purification. Mono-reactive NHS ester of Cy5.5 (Cy5.5-NHS) was purchased from GE Healthcare Corp (Piscataway, NJ, USA). Methanol and dimethyl sulfoxide were anhydrous grade. Iron (III) acetylacetonate, 4-biphenylcarboxylic acid, and benzyl ether were ordered from Thermo Fisher Scientific Inc. (Waltham, MA, USA). Oleic acid was purchased from Sigma-Aldrich Co. CSNRDARRC peptide sequence with 90% purity was manufactured and validated by EZBiolab Inc (Carmel, IN, USA).

Key J., Dhawan D., Cooper C.L., Knapp D.W., Kim K., Kwon I.C., Choi K., Park K., Decuzzi P, & Leary J.F. (2016). Multicomponent, peptide-targeted glycol chitosan nanoparticles containing ferrimagnetic iron oxide nanocubes for bladder cancer multimodal imaging. International Journal of Nanomedicine, 11, 4141-4155.

+ Open protocol

+ Expand

Mesenchymal Stem Cell Transfection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols

MesenCult MSC Basal Medium and MesenCult Stimulatory Supplements were obtained from StemCell Technologies Inc. (Vancouver, Canada). Plasmid DNA coding luciferase enzyme (pGL-3) and Cx43-siRNA was obtained from Sangon Biotechnology Co. Ltd. (Shanghai, China). Plasmid DNA coding for HSV-tk was purchased from InvivoGen Biotechnology Co. (San Diego, USA). GCV was obtained from Haikou Qili Pharmaceutical Co., Ltd. (Hainan, China). 1,1'-Dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (CM-Dil) was obtained from Invitrogen Life Technologies (Carlsbad, USA). Calcein acetoxymethyl ester (calcein-AM), 1% crystal violet and 4',6-diamidino-2-phenylindole (DAPI) were purchased from Yeasen Biotechnology Co. Ltd. (Shanghai, China). Dulbecco's modified Eagle's medium (DMEM) and foetal bovine serum (FBS) were purchased from Gibco BRL (Gaithersburg, USA). Iron (III) acetylacetonate (99%) and 4-biphenylcarboxylic acid (95%) were purchased from Acros Organics (Geel, Belgium). Polycaprolactone (MW = 14,000), oleic acid (90%), and branched polyethylenimine (PEI, MW = 25,000) were purchased from Sigma-Aldrich Chemical Co. (St. Louis, USA). Chloroform and tetrahydrofuran in chemically pure were purchased from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China).

Li A., Zhang T., Huang T., Lin R., Mu J., Su Y., Sun H., Jiang X., Wu H., Xu D., Cao H., Sun X., Ling D, & Gao J. (2021). Iron Oxide Nanoparticles Promote Cx43-Overexpression of Mesenchymal Stem Cells for Efficient Suicide Gene Therapy during Glioma Treatment. Theranostics, 11(17), 8254-8269.

+ Open protocol

+ Expand

Synthesis of Adenosine Derivatives

Check if the same lab product or an alternative is used in the 5 most similar protocols

Adenine (> 99%) and D‐(−)‐ribose (analytical grade) were purchased from TCI EUROPE N.V., and Serva, respectively. Adenosine, D‐(+)‐glucose, cytosine, cytidine, guanine, and guanosine were purchased from Aldrich. Calcium chloride‐dihydrate (≥ 99%) was purchased from Fisher Chemicals. Iron (III)‐acetylacetonate (99+%) and nickel (II)‐acetylacetonate (96%) were from Acros, respectively. Nafion (5 wt. % in a mixture of lower aliphatic alcohols and water, containing 45% water) was from Aldrich. The chemicals were all used as received. The RuO₂ and IrO₂ were purchased from Aldrich, 99.9%

Li C., Lepre E., Bi M., Antonietti M., Zhu J., Fu Y, & López‐Salas N. (2023). Oxygen‐Rich Carbon Nitrides from an Eutectic Template Strategy Stabilize Ni, Fe Nanosites for Electrocatalytic Oxygen Evolution. Advanced Science, 10(22), 2300526.

+ Open protocol

+ Expand

Oligo-PHA Synthesis and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols

Oligo-PHA, tetrahydrofuran (THF; 99%), nitrodopamine-poly(ethylene
glycol) (PEG) carboxylic-terminated ligand (DOPA-PEG), triethylamine
(TEA), toluene (99%), poly(maleic anhydride-alt-1-octadecene),
PC18, M_n 30 000–50 000
(Aldrich), Milli-Q water (18.2 MΩ, filtered with filter pore
size 0.22 μM) from Millipore, chloroform (CHCl₃,
Sigma-Aldrich, 99%), iron(III) acetylacetonate (Acros Organics, 99%),
decanoic acid (Acros Organics, 99%), dibenzyl ether (Acros Organic,
99%), squalene (Alfa Aesar, 98%), and liver porcine esterase(Sigma-Aldrich),
fetal bovine serum (FBS). Pseudomonas mendocina CH50 used for the production of PHA was obtained from the National
Collection of the Industrial and Marine Bacteria (NCIMB 10541). For
the production, characterization and hydrolysis of PHA ammonium sulphate,
potassium dihydrogen phosphate, glucose, magnesium sulphate heptahydrate,
methyl benzoate, and anhydrous sodium sulfate were purchased from
Sigma-Aldrich (Dorset, UK), while disodium hydrogen phosphate, chloroform,
methanol, and THF were purchased from VWR (Poole, UK). All chemicals
were used as supplied without any further purification.

Avugadda S.K., Materia M.E., Nigmatullin R., Cabrera D., Marotta R., Cabada T.F., Marcello E., Nitti S., Artés-Ibañez E.J., Basnett P., Wilhelm C., Teran F.J., Roy I, & Pellegrino T. (2019). Esterase-Cleavable 2D Assemblies of Magnetic Iron Oxide Nanocubes: Exploiting Enzymatic Polymer Disassembling To Improve Magnetic Hyperthermia Heat Losses. Chemistry of Materials, 31(15), 5450-5463.

+ Open protocol

+ Expand

Synthesis of Multifunctional Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols

Ferric chloride hexahydrate (99%), ferrous chloride tetrahydrate (99%), dextran (DX) (M.w. 20,000), zinc chloride (99%), silver nitrate (99.8%), oleylamine (OLA) (70%), benzyl ether (98%), octylphenyl-polyethylene glycol (IGEPAL CA-630), poly(isobutylene-alt-maleic andydride) (PBMA) were purchased from Sigma-Aldrich. Glutathione (GSH) (98%), tetramethylammonium hydroxide (TMAH) (25% solution in methanol), iron(III) acetylacetonate (99%), myristic acid (MA) (99.5%) were purchased from Acros Organics; sodium diethyldithiocarbamate (98%), indium acetate (99.99%), polyethyleneimine (PEI) (99%, M.w. 10,000), zinc acetate (99.98%), copper(I) iodide (99.998%), tetraethylorthosilicate (TEOS) (99%), 3-mercaptopropyltrimethoxysilane (MPTMS) (97%), 1-dodecanethiol (DDT) (98%), dodecylamine (DDA) (98%) were purchased from Alfa Aesar, 3-glycidyloxypropyl-trimethoxysilane (GOPTS) (95%) was from TCI America. All chemical and organic solvents were obtained commercially as analytical-graded materials without further purification.

Koktysh D.S, & Pham W. (2019). A Combinatorial Approach for the Fabrication of Magneto-Optical Hybrid Nanoparticles. International Journal of Nanomedicine, 14, 9855-9863.

+ Open protocol

+ Expand

Synthesis of Magnetic Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols

All chemicals, iron (III) acetylacetonate >99% (Acros Organics); cobalt (II) acetylacetonate 97% (Sigma); manganese (II) acetylacetonate (Sigma); oleic acid >90% (Sigma); dibenzyl ether >99% (Acros Organics); sodium oleate >82% (Sigma); 1-octadecene >90% (Sigma); poly(maleic anhydridealt-1-octadecene) (Sigma); and 1-tetradecene >92% (Sigma) were used as supplied without further purification.
Note that spherical Fe 3 O 4 particles were purchased from Ocean Nanotech® (see SI).

Muro-Cruces J., Roca A.G., López-Ortega A., Fantechi E., Del-Pozo-Bueno D., Estradé S., Peiró F., Sepúlveda B., Pineider F., Sangregorio C, & Nogues J. (2019). Precise Size Control of the Growth of Fe₃O₄ Nanocubes over a Wide Size Range Using a Rationally Designed One-Pot Synthesis. ACS nano, 13(7).

+ Open protocol

+ Expand

Flame Spray Synthesis of Iron Oxide Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols

Pure FeO x and FeO x / SiO 2 were prepared via flame spray pyrolysis, as described elsewhere in detail. 21 In brief, the liquid precursor solution was fed at 2 ml min -1 through a capillary and dispersed by 7 L min -1 O 2 (all gases PanGas, purity > 99%) into fine droplets. The pressure drop over the capillary was constant at 1.6 bar. The formed spray was ignited and stabilized by a premixed CH 4 / O 2 flame (1.5 L min -1 / 3.2 L min -1 ). The resulting spray flame was sheathed by 10 L min -1 O 2 . Particles were formed in the gas phase and collected further downstream on a glass fiber filter (Whatman GF6, 257 mm diameter) with the aid of a vacuum pump (Busch, Seco SV 1040C).
For the precursor solution, iron(III)acetylacetonate (Acros Organics, purity 99+%) was dissolved at a concentration of 0.1 mol Fe L -1 in a 1:1 volume mixture of ethanol and 2-ethylhexanoic acid (both Sigma-Aldrix, purity >97%) and magnetically stirred for at least 1 h. Hexamethyldisiloxane (HMDSO, Sigma-Aldrich, purity ≥ 99%) was added to the solution to attain the desired SiO 2 wt% in the final nanoparticle composition (wt% SiO 2 = m SiO2 / (m SiO2 +m Fe2O3 ) assuming Fe 2 O 3 formation.

Starsich F.H.L., Eberhardt C., Keevend K., Boss A., Hirt A.M., Herrmann I.K, & Pratsinis S.E. (2018). Reduced Magnetic Coupling in Ultrasmall Iron Oxide T₁ MRI Contrast Agents. ACS applied bio materials, 1(3).

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!